[A prospect of genetic tests].
Watanabe
Naoki
N
Department of Clinical Laboratory Medicine, Sapporo Medical University, School of Medicine.
D015415:Biomarkers / Q000032:analysis; D005544:Forecasting; D030342:Genetic Diseases, Inborn / Q000175:diagnosis / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000175:diagnosis; D006801:Humans; D007239:Infections / Q000175:diagnosis; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins / Q000235:genetics; D025202:Molecular Diagnostic Techniques / Q000941:ethics / Q000639:trends*; D009363:Neoplasm Proteins; D009369:Neoplasms / Q000175:diagnosis; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D011296:Prenatal Diagnosis / Q000941:ethics; D011786:Quality Control; D012333:RNA, Messenger / Q000032:analysis; D000077022:Survivin; D019098:Telomerase / Q000235:genetics
C107489:BIRC5 protein, human; D015415:Biomarkers; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D000077022:Survivin; D019098:Telomerase